Specifically, non-overlapping gene expression intervals were observed between OSCA and the other 25 tumor types for MUC16, the other 25 tumor types for PAX8 and the other 29 tumor types for SOX17, and the combination of the three genes may, in principle, discriminate OSCA from any other TCGA-screened tumor type except Uterine Corpus Endometrial Carcinoma (UCEC) and Uterine Carcinosarcoma (UCS) (Figure 4B). This evidence concerns the gene PAX8 and uterine corpus endometrial carcinoma.